Welcome to LookChem.com Sign In|Join Free
  • or
3-iodo-1-isopropyl-1H-pyrazole is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1266115-22-3

Post Buying Request

1266115-22-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1266115-22-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1266115-22-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,6,1,1 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1266115-22:
(9*1)+(8*2)+(7*6)+(6*6)+(5*1)+(4*1)+(3*5)+(2*2)+(1*2)=133
133 % 10 = 3
So 1266115-22-3 is a valid CAS Registry Number.

1266115-22-3Downstream Products

1266115-22-3Relevant academic research and scientific papers

NOVEL PROCESSES

-

Page/Page column 19; 21-23, (2020/05/21)

The present invention relates to processes of preparing N- ((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H- pyrazole-3-sulfonamide and salts thereof. The present invention further relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

TRI-SUBSTITUTED IMIDAZOLES FOR THE INHIBITION OF TGF BETA AND METHODS OF TREATMENT

-

Paragraph 0089, (2019/01/17)

Pharmaceutical compounds, their methods of manufacture, and methods of treatment of mammals with pharmaceutical compounds are provided.

NOVEL COMPOUNDS

-

Page/Page column 178; 179, (2019/11/19)

The present invention relates to substituted 5-membered nitrogen containing heteroaryl compounds, such as sulfonyl triazoles, where the heteroaryl ring is further substituted, optionally via a linking group such as -NH-, with a cyclic group which in turn is substituted at the α-position. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

SYK INHIBITORS

-

Paragraph 2523-2525; 3218-3220, (2016/10/07)

The present disclosure a Syk compound inhibitors, including state cancer and inflammation and various disease States thereof in the treatment of relates to the use of. In one aspect a particular embodiment, . given by formula I which is marked as a chemical structure of compound. In formula said, X 1, X 2, X 3, R 2, R 3, R 4, R 5, and Y has described herein is. The present disclosure of a formula I compounds or a pharmaceutically acceptable salt of pharmaceutical compositions including, mediated by Syk and to treat conditions a employing these compounds and compositions further provides a method. (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1266115-22-3